Panacea Biotec receives ₹9.82 crore income-tax penalty demands
As filed · Panacea Biotec Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
RegulatoryMixedLowmateriality 42 out of 100
What happened
FactPanacea Biotec received four demand orders dated September 25, 2026, from the Assistant Commissioner of Income Tax, Delhi. The orders impose aggregate penalties of approximately ₹9.82 crore for alleged misreporting or under-reporting of income across assessment years 2014-15 to 2016-17 and 2018-19.
Why it matters
CapitSignal interpretationLitigation creates a contingent liability that is not in reported profit until it crystallises.
Scale
- 2.4% of FY26 revenue
₹9.82 Cr stated in the filing against ₹413.49 Cr revenue (FY26, standalone)
Source: financial_facts · exchange_table
Watch next
Fact- Amount claimed against the company
- Whether a provision has been made
- Next hearing or order date
Evidence
How CapitSignal classified this
- Reasoning:
- The company faces a contingent tax demand of approximately ₹9.82 crore. Panacea Biotec considers the demand not maintainable, plans to appeal, and states that it does not expect a significant financial, operational or other impact.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%